Strong Revenue Growth
Bruker reported revenues increased by 14.6% year-over-year in Q4 2024 to $979.6 million, with a constant exchange rate (CER) revenue growth of 15.8% and organic growth of 3.9%.
Above-Market Organic Growth
For fiscal year 2024, Bruker achieved a 4% organic revenue growth, outperforming the market, which was flat to down slightly.
Successful Strategic Acquisitions
Bruker added strategic platforms in spatial biology, molecular diagnostics, and lab automation, contributing to a 10% revenue growth from acquisitions.
Microbiology and Semiconductor Metrology Growth
The microbiology and infectious diagnostics business grew in the mid-teens percentage in Q4, while semiconductor metrology experienced over 20% organic growth.
Improved Operating Margins
Bruker achieved a non-GAAP operating margin of 18.1% in Q4, driven by 300 bps of organic operating margin expansion.